Sign in

CIK 0000920148

  • Large accelerated filer

LABCORP HOLDINGS INC.

Sign in to watch
Ticker
LH
Exchange
NYSE
Industry
Services-Medical Laboratories
FY end
Dec 31
Entity type
Operating
EIN
992588107
Phone
+1 336-229-1127
Business address
358 S MAIN ST, BURLINGTON, NC, 27215
Former names
LABORATORY CORP OF AMERICA HOLDINGS, NATIONAL HEALTH LABORATORIES HOLDINGS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,377,699
in 4 filings, $108K under 10b5-1 plans

Net −$1,377,699. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-08-08 ANDERSON KERRII B Director Sale −5,000 $211.57 $1.1M 15,275
2023-08-01 Wilkinson Peter J SVP, Chief Accounting Officer Exercise or conversion +56 3,488.22
2023-08-01 Wilkinson Peter J SVP, Chief Accounting Officer Shares withheld for taxes −17 $213.61 $4K 3,471.22
2023-08-01 Wilkinson Peter J SVP, Chief Accounting Officer Exercise or conversion · Restricted Stock Unit −56 3,858
2023-06-30 van der Vaart Sandra D EVP, Chief Legal Officer Grant or award · Restricted Stock Unit +6,207 7,974
2023-06-30 Wilkinson Peter J SVP, Chief Accounting Officer Grant or award · Restricted Stock Unit +3,104 3,851
2023-06-30 Summy Amy B. EVP, Chief Marketing Officer Grant or award · Restricted Stock Unit +5,824 7,004
2023-06-30 Schroeder Mark S EVP, Pres Diagnostics & COO Grant or award · Restricted Stock Unit +11,648 14,769
2023-06-30 Schechter Adam H President & CEO Grant or award · Restricted Stock Unit +73,013 89,841
2023-06-30 EISENBERG GLENN A Chief Financial Officer, EVP Grant or award · Restricted Stock Unit +20,193 33,957
2023-06-30 DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl Grant or award · Restricted Stock Unit +3,036 4,700
2023-06-30 Caveney Brian J EVP, Pres of ED, CMO & CSO Grant or award · Restricted Stock Unit +11,648 14,629
2023-06-30 BERBERIAN LANCE EVP, CIO & CTO Grant or award · Restricted Stock Unit +7,758 9,585
2023-06-29 van der Vaart Sandra D EVP, Chief Legal Officer Sale 10b5-1 −212 $240.00 $51K 7,604.7
2023-06-06 Rothman Paul Director Grant or award · Restricted Stock Unit +642 642
2023-05-19 Kirchgraber Paul R CEO, Covance Drug Development Exercise or conversion +4,300 $182.51 $785K 17,246
2023-05-19 Kirchgraber Paul R CEO, Covance Drug Development Sale −4,300 $216.91 $933K 12,946
2023-05-19 Kirchgraber Paul R CEO, Covance Drug Development Exercise or conversion · Non-qualified Stock Options −4,300 0
2023-05-18 Schroeder Mark S EVP, Pres Diagnostics & COO Exercise or conversion 10b5-1 +1,500 $130.60 $196K 8,187.4
2023-05-18 Schroeder Mark S EVP, Pres Diagnostics & COO Sale 10b5-1 −1,500 $216.77 $325K 6,687.4

Page 36 of 41 · 816 trades